The number of biological samples in the Biobank Research Group’s collections has increased by 500%. As a result, the Population Diagnostics Center, led by Dr. hab. Patrycja Gazińska, has reached one of the key milestones in the P4Health project, funded under the Teaming for Excellence program.
This marks an important stage in the development of research infrastructure for personalized medicine and translational research. Biobanking is one of the foundations of modern diagnostics and therapy, enabling high-quality biological material to be linked with well-described, securely managed data. Resources created in this way support biomarker identification, the analysis of disease mechanisms, and the development of more precise therapeutic strategies.
As part of the Teaming for Excellence project, jointly implemented by the Population Diagnostics Center and the P4Health Center, biobanking is one of the key components of the research infrastructure supporting the development of precision medicine. The Biobank serves as one of the main technology platforms, enabling the collection of biological material and clinical data, their storage, processing, and analysis, and ultimately the development of solutions for use in clinical practice.
In parallel, the Biobank Research Group is developing a cyber-lab with advanced IT infrastructure and applications that support biobanking processes, data archiving and integration from various sources, as well as the secure management of biomedical information in line with the highest standards of quality and data protection. This makes it possible to effectively integrate biological, clinical, molecular, and imaging data, providing the foundation for modern translational research and the implementation of innovative diagnostic solutions.
“When samples arrive at our institute, the Biobank Research Group team first ensures that they are properly secured and that their high quality and research value are preserved. This includes, among other things, registering the material and providing appropriate storage conditions in accordance with applicable procedures, as well as maintaining their integrity with the associated data. As a result, the samples retain their research value for many years,” emphasizes Dr. hab. Patrycja Gazińska.
“A key task is making this material available to researchers. Every use of the material is carried out in accordance with applicable regulations, ethical principles, and the participant’s consent. Behind every sample are the commitment of patients, the work of clinical teams, and the expertise of specialists in biobanking. It is precisely thanks to the collaboration of all these people that research leading to discoveries becomes possible – discoveries that may benefit future patients,” she adds.
Although formal completion of this stage of the project is scheduled for October 31, 2028, the target indicator has already been achieved. This result confirms the effectiveness of the operational and scientific activities carried out at the Population Diagnostics Center and strengthens the potential of Łukasiewicz – PORT in biomedical research, personalized medicine, and the responsible management of biological resources.
Reaching this milestone opens the next stage of work, which includes further expanding the collection, developing biobanking infrastructure, and broadening the scope of research conducted under P4Health.
